Total Artificial Heart Implantation Blood Pressure Management as Resolving Treatment for Massive Hemolysis following Total Artificial Heart Implantation.
作者信息
Ghodsizad Ali, Koerner Michael M, El-Banayosy A, Zeriouh Mohamed, Ruhparwar Arjang, Loebe Matthias
机构信息
Division of Thoracic Transplantation and MCS, Miami Transplant Institute, University of Miami, Jackson Memoral Hospital, Miami, Flordia, USA.
Heart and Vascular Institute, Pennstate Milton Hershey Medical Center, Penn State College of Medicine, Hershey Pennsylvania, USA.
出版信息
Heart Surg Forum. 2016 Oct 21;19(5):E229. doi: 10.1532/hsf.1633.
The SynCardia Total Artificial Heart (TAH) has been used for patients with biventricular failure, who cannot be managed with implantation of a left ventricular (LV) assist device. Following TAH implantation, our patient developed severe hemolysis, which could only be managed successfully by aggressive blood pressure control [Ohashi 2003; Nakata 1998].
Zotero 插件